News | Artificial Intelligence | November 09, 2023

Further enhancing comprehensive trauma care solution 

Further enhancing comprehensive trauma care solution

November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma. 

Together with Rapid ICH and Rapid Hyperdensity, the three modules comprise RapidAI’s unique and industry-best hemorrhagic and trauma care AI solution, designed to help teams on the front lines of patient assessment streamline decision making and expedite patient care. 

The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040 and current estimated mortality rates at 40-60% – underscored by neurosurgical workforce shortages across the country. Rapid SDH leverages AI and the intelligence gained from analyzing hundreds of patient scans to help neurocritical care teams identify suspected hemispheric subdural hemorrhage faster and with a higher degree of accuracy than traditional methods. With the advanced Rapid mobile app, Rapid SDH automatically sends results to the entire trauma team across the hospital system or treatment network, enabling clinicians to make more timely and informed transfer and treatment decisions for patients with traumatic brain injury or hemorrhagic stroke. 

Key features of Rapid SDH and the trauma care solution include: 

  • The only hemorrhagic and trauma package to feature hemispheric SDH, ICH and Hyperdensity for faster and complete patient assessment 
  • Rapid SDH offers industry leading Positive Predictive Value (PPV) of 99% (sensitivity 93%, specificity 99%) for suspected acute and chronic hemispheric subdural hematomas >1mL 
  • Faster results by notifying clinicians in 1 minute or less 
  • Automatically sends notifications through the Rapid mobile app, PACS, and email, facilitating treatment and transfer decisions of patients with subdural hematomas 

"The FDA's clearance of Rapid SDH significantly enhances our expanding range of hemorrhagic and trauma care solutions at this crucial time of rapidly growing patient numbers, clinician shortages, and advancements in potential treatment options,” said Amit Phadnis, CTO of RapidAI. “Our goal is to continue to expand the capabilities and applications of our deep AI to deliver comprehensive clinical solutions that provide care teams with the crucial insights necessary to evaluate patients, streamline decision making, and expedite care for this common and dangerous disease.” 

For more information: rapidai.com/rapid-sdh 

Find more RSNA23 conference coverage here 


Related Content

News | RSNA

December 1, 2023 — Royal Philips, a global leader in health technology, put patients and healthcare providers center ...

Time December 01, 2023
arrow
News | RSNA

December 1, 2023 —Nuance Communications, Inc., a Microsoft Company, during the 2023 Radiological Society of North ...

Time December 01, 2023
arrow
News | RSNA

December 1, 2023 — In today's healthcare environment, the industry faces various pressing challenges. The magnetic ...

Time December 01, 2023
arrow
News | RSNA

December 1, 2023 — The Society of Breast Imaging (SBI) announced that Elizabeth Morris, MD, has been selected as the SBI ...

Time November 30, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 30, 2023 — Royal Philips, a global leader in health technology, today launched three new fit for purpose MR ...

Time November 30, 2023
arrow
News | Radiology Imaging

November 30, 2023 — Through its leading imaging solutions and commitment to innovation, GE HealthCare remains at the ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Hologic, Inc. showcased several recent developments in next-generation AI solutions at the 109th ...

Time November 30, 2023
arrow
News | Pediatric Imaging

November 30, 2023 — Youth baseball players are prone to elbow pain and injuries, including repetitive overuse changes ...

Time November 30, 2023
arrow
News | RSNA

November 30, 2023 — Breast cancer mortality is significantly reduced when women regularly attend screening mammograms ...

Time November 30, 2023
arrow
News | Artificial Intelligence

November 29, 2023 — The Radiological Society of North America (RSNA) has announced the results of the “RSNA Abdominal ...

Time November 29, 2023
arrow
Subscribe Now